DE202020107535U1 - UV-transparente Gläser zum Beseitigen von Methicillin-resistenten Staphylococcus aureus - Google Patents
UV-transparente Gläser zum Beseitigen von Methicillin-resistenten Staphylococcus aureus Download PDFInfo
- Publication number
- DE202020107535U1 DE202020107535U1 DE202020107535.7U DE202020107535U DE202020107535U1 DE 202020107535 U1 DE202020107535 U1 DE 202020107535U1 DE 202020107535 U DE202020107535 U DE 202020107535U DE 202020107535 U1 DE202020107535 U1 DE 202020107535U1
- Authority
- DE
- Germany
- Prior art keywords
- glass
- mol
- ppm
- glasses
- bao
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011521 glass Substances 0.000 title claims abstract description 311
- 241000191967 Staphylococcus aureus Species 0.000 title claims description 8
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 title claims description 7
- 229960003085 meticillin Drugs 0.000 title claims description 7
- 230000005540 biological transmission Effects 0.000 claims abstract description 76
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 45
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 20
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 14
- 239000005388 borosilicate glass Substances 0.000 claims abstract description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 43
- 238000004659 sterilization and disinfection Methods 0.000 claims description 35
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 24
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 229910018068 Li 2 O Inorganic materials 0.000 claims description 18
- 238000004458 analytical method Methods 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 14
- 230000002070 germicidal effect Effects 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 10
- 238000007789 sealing Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 9
- 229910052719 titanium Inorganic materials 0.000 claims description 9
- 239000010936 titanium Substances 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 8
- 230000008030 elimination Effects 0.000 claims description 8
- 238000003379 elimination reaction Methods 0.000 claims description 8
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 7
- 229910052753 mercury Inorganic materials 0.000 claims description 7
- 238000012544 monitoring process Methods 0.000 claims description 6
- 201000009053 Neurodermatitis Diseases 0.000 claims description 5
- 201000004681 Psoriasis Diseases 0.000 claims description 5
- 229910006404 SnO 2 Inorganic materials 0.000 claims description 5
- 206010047642 Vitiligo Diseases 0.000 claims description 5
- 206010000496 acne Diseases 0.000 claims description 5
- 238000004163 cytometry Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 208000017983 photosensitivity disease Diseases 0.000 claims description 5
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 4
- 208000003251 Pruritus Diseases 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 238000004887 air purification Methods 0.000 claims description 4
- 230000000903 blocking effect Effects 0.000 claims description 4
- 230000035876 healing Effects 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 238000001459 lithography Methods 0.000 claims description 4
- 238000001126 phototherapy Methods 0.000 claims description 4
- 206010035114 pityriasis rosea Diseases 0.000 claims description 4
- 230000008635 plant growth Effects 0.000 claims description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 4
- 235000005282 vitamin D3 Nutrition 0.000 claims description 4
- 239000011647 vitamin D3 Substances 0.000 claims description 4
- 229940021056 vitamin d3 Drugs 0.000 claims description 4
- 229910052793 cadmium Inorganic materials 0.000 claims description 3
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 3
- JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) Chemical compound [Cr+6] JOPOVCBBYLSVDA-UHFFFAOYSA-N 0.000 claims description 3
- 238000007876 drug discovery Methods 0.000 claims description 3
- 230000007803 itching Effects 0.000 claims description 3
- 229910052703 rhodium Inorganic materials 0.000 claims description 3
- 239000010948 rhodium Substances 0.000 claims description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 33
- 239000000463 material Substances 0.000 description 29
- 239000011734 sodium Substances 0.000 description 27
- 238000005191 phase separation Methods 0.000 description 23
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Inorganic materials [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 22
- 238000000034 method Methods 0.000 description 21
- 238000011109 contamination Methods 0.000 description 20
- 230000005855 radiation Effects 0.000 description 20
- 238000013461 design Methods 0.000 description 15
- 241000219739 Lens Species 0.000 description 13
- 210000001508 eye Anatomy 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 229910010413 TiO 2 Inorganic materials 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 239000007789 gas Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 241000282414 Homo sapiens Species 0.000 description 8
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- 239000000919 ceramic Substances 0.000 description 7
- 229910052805 deuterium Inorganic materials 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 231100000433 cytotoxic Toxicity 0.000 description 5
- 230000001472 cytotoxic effect Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000005260 human cell Anatomy 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000010453 quartz Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000007493 shaping process Methods 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 4
- 229910052787 antimony Inorganic materials 0.000 description 4
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000000254 damaging effect Effects 0.000 description 3
- 238000003280 down draw process Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 230000009477 glass transition Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 231100000219 mutagenic Toxicity 0.000 description 3
- 230000003505 mutagenic effect Effects 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 239000012780 transparent material Substances 0.000 description 3
- 241000238421 Arthropoda Species 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000270322 Lepidosauria Species 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 206010034944 Photokeratitis Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- PMHQVHHXPFUNSP-UHFFFAOYSA-M copper(1+);methylsulfanylmethane;bromide Chemical compound Br[Cu].CSC PMHQVHHXPFUNSP-UHFFFAOYSA-M 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000000156 glass melt Substances 0.000 description 2
- 239000002241 glass-ceramic Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- -1 methacrylate ester Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008646 thermal stress Effects 0.000 description 2
- 229910052718 tin Inorganic materials 0.000 description 2
- 239000002132 β-lactam antibiotic Substances 0.000 description 2
- 229940124586 β-lactam antibiotics Drugs 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241001466804 Carnivora Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000306001 Cetartiodactyla Species 0.000 description 1
- 241000288673 Chiroptera Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000282418 Hominidae Species 0.000 description 1
- 241000289658 Insectivora Species 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 206010048723 Multiple-drug resistance Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000283216 Phocidae Species 0.000 description 1
- 241000101040 Pityriasis Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000288726 Soricidae Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000032912 absorption of UV light Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000005391 art glass Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 150000001782 cephems Chemical class 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000004031 devitrification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 210000000959 ear middle Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- FUJCRWPEOMXPAD-UHFFFAOYSA-N lithium oxide Chemical compound [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000006060 molten glass Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000478 neocortex Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000002959 penams Chemical class 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 201000004768 pinguecula Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/11—Glass compositions containing silica with 40% to 90% silica, by weight containing halogen or nitrogen
- C03C3/112—Glass compositions containing silica with 40% to 90% silica, by weight containing halogen or nitrogen containing fluorine
- C03C3/115—Glass compositions containing silica with 40% to 90% silica, by weight containing halogen or nitrogen containing fluorine containing boron
- C03C3/118—Glass compositions containing silica with 40% to 90% silica, by weight containing halogen or nitrogen containing fluorine containing boron containing aluminium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0047—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/26—Accessories or devices or components used for biocidal treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
- A61L9/18—Radiation
- A61L9/20—Ultraviolet radiation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
- C02F1/32—Treatment of water, waste water, or sewage by irradiation with ultraviolet light
- C02F1/325—Irradiation devices or lamp constructions
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/089—Glass compositions containing silica with 40% to 90% silica, by weight containing boron
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/089—Glass compositions containing silica with 40% to 90% silica, by weight containing boron
- C03C3/091—Glass compositions containing silica with 40% to 90% silica, by weight containing boron containing aluminium
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/089—Glass compositions containing silica with 40% to 90% silica, by weight containing boron
- C03C3/091—Glass compositions containing silica with 40% to 90% silica, by weight containing boron containing aluminium
- C03C3/093—Glass compositions containing silica with 40% to 90% silica, by weight containing boron containing aluminium containing zinc or zirconium
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/11—Glass compositions containing silica with 40% to 90% silica, by weight containing halogen or nitrogen
- C03C3/112—Glass compositions containing silica with 40% to 90% silica, by weight containing halogen or nitrogen containing fluorine
- C03C3/115—Glass compositions containing silica with 40% to 90% silica, by weight containing halogen or nitrogen containing fluorine containing boron
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/0085—Compositions for glass with special properties for UV-transmitting glass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/25—Rooms in buildings, passenger compartments
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/32—Details relating to UV-irradiation devices
- C02F2201/322—Lamp arrangement
- C02F2201/3222—Units using UV-light emitting diodes [LED]
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C2204/00—Glasses, glazes or enamels with special properties
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W10/00—Technologies for wastewater treatment
- Y02W10/30—Wastewater or sewage treatment systems using renewable energies
- Y02W10/37—Wastewater or sewage treatment systems using renewable energies using solar energy
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Geochemistry & Mineralogy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Glass Compositions (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21175361.1A EP4008360A1 (en) | 2020-12-03 | 2021-05-21 | Method for eradicating pathogens |
| JP2021135578A JP7293295B2 (ja) | 2020-12-03 | 2021-08-23 | メチシリン耐性スタフィロコッカス・アウレウスの除去方法 |
| JP2021135574A JP7374151B2 (ja) | 2020-12-03 | 2021-08-23 | ホウケイ酸ガラス物品 |
| CN202111194279.8A CN114601941B (zh) | 2020-12-03 | 2021-10-13 | 用于根除耐甲氧西林金黄色葡萄球菌的方法 |
| CN202111192706.9A CN114590995B (zh) | 2020-12-03 | 2021-10-13 | 硼硅酸盐玻璃制品 |
| CN202111464974.1A CN114588288A (zh) | 2020-12-03 | 2021-12-03 | 用于根除病原体的方法 |
| JP2021197213A JP2022089195A (ja) | 2020-12-03 | 2021-12-03 | 病原体の根絶方法 |
| US17/541,759 US20220177354A1 (en) | 2020-12-03 | 2021-12-03 | Method for eradicating pathogens |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20211687.7 | 2020-12-03 | ||
| EP20211687 | 2020-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE202020107535U1 true DE202020107535U1 (de) | 2021-04-28 |
Family
ID=73792928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE202020107535.7U Active DE202020107535U1 (de) | 2020-12-03 | 2020-12-23 | UV-transparente Gläser zum Beseitigen von Methicillin-resistenten Staphylococcus aureus |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20220177352A1 (enExample) |
| EP (2) | EP4008360A1 (enExample) |
| JP (2) | JP3233968U (enExample) |
| CN (1) | CN114588288A (enExample) |
| DE (1) | DE202020107535U1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4008360A1 (en) * | 2020-12-03 | 2022-06-08 | Schott Ag | Method for eradicating pathogens |
| CN115368016A (zh) * | 2021-05-21 | 2022-11-22 | 肖特股份有限公司 | 具有高uv透射率和高耐晒性的玻璃 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11964062B2 (en) | 2019-09-03 | 2024-04-23 | Luxhygenix Inc. | Antimicrobial device using ultraviolet light |
| JP7374151B2 (ja) * | 2020-12-03 | 2023-11-06 | ショット アクチエンゲゼルシャフト | ホウケイ酸ガラス物品 |
| JP2023060459A (ja) * | 2021-10-18 | 2023-04-28 | スタンレー電気株式会社 | Ｌｅｄランプ装置およびｌｅｄランプ装置を備えたコンソールボックス構造 |
| EP4180401B1 (en) | 2021-10-19 | 2024-06-05 | Schott Ag | Glass, glass article, method of making the glass, use of the glass and flash lamp comprising the glass |
| JP2023162698A (ja) | 2022-04-27 | 2023-11-09 | 国立大学法人山口大学 | 紫外線照射装置および紫外線照射方法 |
| EP4345076B1 (en) * | 2022-09-27 | 2025-12-10 | Schott Ag | Glass for radiation and/or particle detectors |
| WO2024150554A1 (ja) * | 2023-01-11 | 2024-07-18 | ウシオ電機株式会社 | 藻類又は微生物の増殖抑制方法、紫外線照射装置、及び照明装置 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3320980C2 (de) * | 1983-06-10 | 1987-01-15 | Schott Glaswerke, 6500 Mainz | Aggregat zum Schmelzen von Glas |
| JPS6046946A (ja) * | 1983-08-19 | 1985-03-14 | Nippon Sheet Glass Co Ltd | 紫外線透過ガラス |
| JPS6287433A (ja) * | 1985-10-12 | 1987-04-21 | Minolta Camera Co Ltd | 紫外線透過ガラス |
| DE3801840A1 (de) * | 1988-01-20 | 1989-08-03 | Schott Glaswerke | Uv-durchlaessiges glas |
| CA2299692C (en) * | 1999-03-01 | 2007-09-18 | Johnson & Johnson Vision Care, Inc. | Method of sterilization |
| DE19955827B4 (de) | 1999-11-20 | 2005-03-31 | Schott Ag | Verfahren zur Unterdrückung der Bildung von O2-Gasblasen an der Kontaktfläche zwischen einer Glasschmelze und Edelmetall |
| CN101511742B (zh) * | 2006-09-04 | 2011-05-11 | 日本电气硝子株式会社 | 玻璃的制造方法 |
| DE102009021115B4 (de) * | 2009-05-13 | 2017-08-24 | Schott Ag | Silicatgläser mit hoher Transmission im UV-Bereich, ein Verfahren zu deren Herstellung sowie deren Verwendung |
| DE102011112994A1 (de) * | 2011-09-08 | 2013-03-14 | Schott Ag | Vorrichtung zur Entkeimung von Gasen und/oder Flüssigkeiten |
| US9145333B1 (en) * | 2012-05-31 | 2015-09-29 | Corning Incorporated | Chemically-strengthened borosilicate glass articles |
| TWI692459B (zh) * | 2015-05-29 | 2020-05-01 | 日商Ａｇｃ股份有限公司 | 紫外線透射玻璃 |
| JP6847053B2 (ja) * | 2015-06-03 | 2021-03-24 | ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | 選択的にウイルスに影響を及ぼすかおよび／またはそれを死滅させるための装置、方法およびシステム |
| WO2018131582A1 (ja) * | 2017-01-10 | 2018-07-19 | ウシオ電機株式会社 | 紫外線殺菌装置 |
| JP7119534B2 (ja) * | 2018-04-24 | 2022-08-17 | ウシオ電機株式会社 | 乾燥殺菌装置および乾燥殺菌方法 |
| CN110240402B (zh) * | 2019-06-28 | 2021-09-28 | 中国建筑材料科学研究总院有限公司 | 一种环保型透深紫外硼硅酸盐玻璃及其制备方法、应用 |
| CN112209617A (zh) * | 2020-09-28 | 2021-01-12 | 佛山千里目科技有限公司 | 一种紫外线波段高透过率多组分硅酸盐玻璃及其制备方法 |
| DE202020107535U1 (de) * | 2020-12-03 | 2021-04-28 | Schott Ag | UV-transparente Gläser zum Beseitigen von Methicillin-resistenten Staphylococcus aureus |
-
2020
- 2020-12-23 DE DE202020107535.7U patent/DE202020107535U1/de active Active
-
2021
- 2021-02-25 JP JP2021000631U patent/JP3233968U/ja active Active
- 2021-05-21 EP EP21175361.1A patent/EP4008360A1/en active Pending
- 2021-08-17 EP EP21191643.2A patent/EP3960206B1/en active Active
- 2021-12-03 JP JP2021197213A patent/JP2022089195A/ja active Pending
- 2021-12-03 CN CN202111464974.1A patent/CN114588288A/zh active Pending
- 2021-12-03 US US17/541,793 patent/US20220177352A1/en active Pending
- 2021-12-03 US US17/541,759 patent/US20220177354A1/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4008360A1 (en) * | 2020-12-03 | 2022-06-08 | Schott Ag | Method for eradicating pathogens |
| CN115368016A (zh) * | 2021-05-21 | 2022-11-22 | 肖特股份有限公司 | 具有高uv透射率和高耐晒性的玻璃 |
| CN115368016B (zh) * | 2021-05-21 | 2024-05-24 | 肖特股份有限公司 | 具有高uv透射率和高耐晒性的玻璃 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3960206A2 (en) | 2022-03-02 |
| JP2022089195A (ja) | 2022-06-15 |
| CN114588288A (zh) | 2022-06-07 |
| US20220177354A1 (en) | 2022-06-09 |
| US20220177352A1 (en) | 2022-06-09 |
| EP3960206A3 (en) | 2022-06-15 |
| EP4008360A1 (en) | 2022-06-08 |
| JP3233968U (ja) | 2021-09-09 |
| EP3960206B1 (en) | 2025-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE202020107535U1 (de) | UV-transparente Gläser zum Beseitigen von Methicillin-resistenten Staphylococcus aureus | |
| DE69626313T2 (de) | Desaktivierung von organischen mit polychromatischem hochintensitätspulslicht | |
| DE69519436T2 (de) | Verfahren zur Sterilisierung eines Hilfsmittels für Augen | |
| CN114601941B (zh) | 用于根除耐甲氧西林金黄色葡萄球菌的方法 | |
| EP1496114A1 (de) | Verfahren zur Inaktivierung von Mikroorganismen | |
| DE69735558T2 (de) | Verwendung von Bronopol zur Behandlung von Krankheiten von Fischeiern | |
| Hayes et al. | Inactivation of recalcitrant protozoan oocysts and bacterial endospores in drinking water using high-intensity pulsed UV light irradiation | |
| Chatterjee et al. | Benzoic acid treated Drosophila melanogaster: the genetic disruption of larval brain stem cells and non-neural cells during metamorphosis | |
| CN1327741A (zh) | 溶葡萄球菌复合酶消毒剂 | |
| DE19532800A1 (de) | UV-aktive Werkstoffe und ihre Verwendung | |
| Profeta et al. | Evaluation of veterinary autogenous vaccines safety by an MTT in-vitro cytotoxicity assay | |
| Hegner | Excystation in vitro of human intestinal protozoa | |
| CH644087A5 (en) | Process and agent for maintaining the sterility of water and aqueous solutions | |
| Burnett et al. | Hydrogel encapsulation of living organisms for long-term microscopy | |
| Fukushi et al. | Reactive oxygen species are involved in inhibition of photoreactivation of Staphylococcus aureus irradiated with 222‐nm Far ultraviolet C | |
| CN112603928A (zh) | 一种消毒剂和洗涤剂联产方法及消毒剂 | |
| DE102023115010B4 (de) | Wasch- und/oder Desinfektionsmittel zum Waschen und/oder Desinfizieren | |
| CN111838175A (zh) | 一种安全无刺激可以入口的消毒剂配方及其生产工艺 | |
| Al-Abodi | Synergistic Efficacy of Methanolic Extract of Nerium oleander Leaf Combined with Praziquantel against Hydatid Cyst Protoscolices. | |
| Stockton-Fiti et al. | Evaluation of Atlantium’s Medium Pressure Columnated Beam on various life stages of New Zealand mudsnails (Potamopyrgus antipodarum) | |
| Li et al. | Inactivation effect and damage of multi-irradiance by UVCLED on Acinetobacter baumannii | |
| Eleinen et al. | Novel Data About Unusual Location of Toxoplasma Gondii Within Active Microbial Community in the Anterior Chamber of the Eye of Egyptian Rural Children | |
| DE202024104738U1 (de) | Zusammensetzung eines bestrahlten Impfstoffs gegen Aeromonas-Arten | |
| Ibrahim | Study Physical Properties of activated antimicrobial agents by diode Laser and its effect on Pathogenic bacteria | |
| DE102012210055B4 (de) | Nachweis der Viabilität biologischer Proben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R207 | Utility model specification | ||
| R150 | Utility model maintained after payment of first maintenance fee after three years |